Protein arginine methyltransferase 5: a potential cancer therapeutic target.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 33, doi. 10.1007/s13402-020-00577-7
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2021 AND VI 44 AND IP 1
Results: 16
1
2
Correction to: LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
3
LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA6.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 219, doi. 10.1007/s13402-020-00563-z
- By:
- Publication type:
- Article
4
Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 77, doi. 10.1007/s13402-020-00554-0
- By:
- Publication type:
- Article
5
Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 61, doi. 10.1007/s13402-020-00522-8
- By:
- Publication type:
- Article
6
Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 205, doi. 10.1007/s13402-020-00562-0
- By:
- Publication type:
- Article
7
The Duchenne muscular dystrophy gene and cancer.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 19, doi. 10.1007/s13402-020-00572-y
- By:
- Publication type:
- Article
8
Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 1, doi. 10.1007/s13402-020-00570-0
- By:
- Publication type:
- Article
9
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 193, doi. 10.1007/s13402-020-00561-1
- By:
- Publication type:
- Article
10
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 45, doi. 10.1007/s13402-020-00500-0
- By:
- Publication type:
- Article
11
Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 179, doi. 10.1007/s13402-020-00560-2
- By:
- Publication type:
- Article
12
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 167, doi. 10.1007/s13402-020-00559-9
- By:
- Publication type:
- Article
13
Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 151, doi. 10.1007/s13402-020-00558-w
- By:
- Publication type:
- Article
14
Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 135, doi. 10.1007/s13402-020-00557-x
- By:
- Publication type:
- Article
15
Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial–mesenchymal transition through targeting major vault protein (MVP).
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 109, doi. 10.1007/s13402-020-00556-y
- By:
- Publication type:
- Article
16
Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC2.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 1, p. 93, doi. 10.1007/s13402-020-00555-z
- By:
- Publication type:
- Article